Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-based AIS for Refractory Insomnia
NCT07255027Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
01
Overview
Randomised trial of dexmedetomidine in Insomnia (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Percentage of NREM-N3 sleep within total sleep time at 7 days. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT07255027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07255027.